Ibrutinib in patients with atrial fibrillation - the challenge of thromboembolic prophylaxis

Ibrutinib is a novel drug used in haematological malignancies. Its use is associated with an increased risk of atrial fibrillation (AF), which, in turn, exposes patients to embolic risk, including stroke. Reducing this risk requires anticoagulant therapy which is a matter of concern in the context o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ciuculete Denisa-Corina (Autore), Popescu Raluca Alexandra (Autore), Dan Gheorghe-Andrei (Autore)
Natura: Libro
Pubblicazione: Sciendo, 2021-09-01T00:00:00Z.
Soggetti:
Accesso online:Connect to this object online.
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Accesso online

Connect to this object online.

3rd Floor Main Library

Dettagli sul posseduto da 3rd Floor Main Library
Collocazione: A1234.567
Copia 1 Disponibile